Fariborz Ghaffarpasand1, Mostafa Shahrezaei2, Maryam Dehghankhalili3. 1. Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz, Iran. 2. Department of Orthopedic Surgery, AJA University of Medical Sciences, Tehran, Iran. 3. Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Abstract
OBJECTIVE: To determine the effects of platelet rich plasma PRP on healing rates of long bone non-union fracture. METHOD: This was a randomized double-blind placebo controlled clinical trial being performed in a 12-month period. We included 75 adult (>18 years) patients suffering from long bone (Femur, Tibia, Humerus and Ulna) non-union fracture who were randomly assigned to receive 5mL PRP (n=37) or 5mL normal saline as placebo (n=38) in the site of fracture after intramedullary nailing or open reduction and internal fixation (ORIF) along with autologous bone graft. Patients were followed each 45 days till 9 months and were evaluated both clinically and radiologically in each visit. The healing rate, failure rate, incidence of infection, mal-union and limb shortening were recorded and compared between groups after 9 months of follow-up. RESULTS: The healing rate was significantly higher in PRP group compared to placebo (81.1% vs. 55.3%; p=0.025). The limb shortening was significantly higher in those who received placebo (2.61±1.5 vs. 1.88±1.2mm; p=0.030). Injection of PRP was also associated with lower pain scores ( p=0.003) and shorter healing duration ( p=0.046). The surgical site infection ( p=0.262) and mal-union rate ( p=0.736) were comparable between groups. CONCLUSION: Application of PRP along with autologous bone graft in the site of non-union of long bone after intramedullary nailing or ORIF results in higher cure rate, shorter healing duration, lower limb shortening and less postoperative pain. Higher infection rate might be a complication of PRP application. CLINICAL TRIAL REGISTRY: This trial is registered with the Iranian Clinical Trials Registry (IRCT201208262445N1; www.irct.ir).
RCT Entities:
OBJECTIVE: To determine the effects of platelet rich plasma PRP on healing rates of long bone non-union fracture. METHOD: This was a randomized double-blind placebo controlled clinical trial being performed in a 12-month period. We included 75 adult (>18 years) patients suffering from long bone (Femur, Tibia, Humerus and Ulna) non-union fracture who were randomly assigned to receive 5mL PRP (n=37) or 5mL normal saline as placebo (n=38) in the site of fracture after intramedullary nailing or open reduction and internal fixation (ORIF) along with autologous bone graft. Patients were followed each 45 days till 9 months and were evaluated both clinically and radiologically in each visit. The healing rate, failure rate, incidence of infection, mal-union and limb shortening were recorded and compared between groups after 9 months of follow-up. RESULTS: The healing rate was significantly higher in PRP group compared to placebo (81.1% vs. 55.3%; p=0.025). The limb shortening was significantly higher in those who received placebo (2.61±1.5 vs. 1.88±1.2mm; p=0.030). Injection of PRP was also associated with lower pain scores ( p=0.003) and shorter healing duration ( p=0.046). The surgical site infection ( p=0.262) and mal-union rate ( p=0.736) were comparable between groups. CONCLUSION: Application of PRP along with autologous bone graft in the site of non-union of long bone after intramedullary nailing or ORIF results in higher cure rate, shorter healing duration, lower limb shortening and less postoperative pain. Higher infection rate might be a complication of PRP application. CLINICAL TRIAL REGISTRY: This trial is registered with the Iranian Clinical Trials Registry (IRCT201208262445N1; www.irct.ir).
Entities:
Keywords:
Intramedullary nailing; Long bone fracture; Non-union; Open reduction and internal fixation (ORIF); Platelet rich plasma (PRP)
Authors: Giorgio Maria Calori; Mario D'Avino; Lorenzo Tagliabue; Walter Albisetti; Marco d'Imporzano; Giovanni Peretti Journal: Injury Date: 2006-09 Impact factor: 2.586
Authors: Angelos Kaspiris; Argyris C Hadjimichael; Elias S Vasiliadis; Dionysios J Papachristou; Peter V Giannoudis; Elias C Panagiotopoulos Journal: J Clin Med Date: 2022-07-04 Impact factor: 4.964
Authors: Christian Andersen; Nicholas M Wragg; Maryam Shariatzadeh; Samantha Louise Wilson Journal: Curr Osteoporos Rep Date: 2021-01-04 Impact factor: 5.096